Protein Domain : IPR008129

Type:  Family Name:  Glycine receptor alpha2
Description:  Neurotransmitter ligand-gated ion channels are transmembrane receptor-ion channel complexes that open transiently upon binding of specific ligands, allowing rapid transmission of signals at chemical synapses [, ]. Five of these ion channel receptor families have been shown to form a sequence-related superfamily:Nicotinic acetylcholine receptor (AchR), an excitatory cation channel in vertebrates and invertebrates; in vertebrate motor endplates it is composed of alpha, beta, gamma and delta/epsilon subunits; in neurons it is composed of alpha and non-alpha (or beta) subunits [].Glycine receptor, an inhibitory chloride ion channel composed of alpha and beta subunits [].Gamma-aminobutyric acid (GABA) receptor, an inhibitory chloride ion channel; at least four types of subunits (alpha, beta, gamma and delta) are known [].Serotonin 5HT3 receptor, of which there are seven major types (5HT3-5HT7) [].Glutamate receptor, an excitatory cation channel of which at least three types have been described (kainate, N-methyl-D-aspartate (NMDA) and quisqualate) [].These receptors possess a pentameric structure (made up of varying subunits), surrounding a central pore. All known sequences of subunits from neurotransmitter-gated ion-channels are structurally related. They are composed of a large extracellular glycosylated N-terminal ligand-binding domain, followed by three hydrophobic transmembrane regions which form the ionic channel, followed by an intracellular region of variable length. A fourth hydrophobic region is found at the C-terminal of the sequence [, ].Glycine is a major inhibitory neurotransmitter (NT) in the adult vertebrate central nervous system (CNS). Glycinergic synapses have a well-establishedrole in the processing of motor and sensory information that controls movement, vision and audition []. This action of glycine is mediatedthrough its interaction with the glycine receptor (GlyR): an intrinsic chloride channel is opened in response to agonist binding. The subsequentinflux of anions prevents membrane depolarisation and neuronal firing induced by excitatory NTs. Strychnine acts as a competitive antagonist ofglycine binding, thereby reducing the activity of inhibitory neurones. Poisoning with strychnine is characterised by over-excitation, muscle spasmsand convulsions. Whilst glycine is the principal physiological agonist at GlyRs, taurine and beta-alanine also behave as agonists []. Compounds thatmodulate GlyR activity include zinc, some alcohols and anaesthetics, picrotoxin, cocaine and some anticonvulsants. GlyRs were thought for sometime to be localised exclusively in the brain stem and spinal cord, but have since been found to be expressed more widely, including the cochlear nuclei,cerebellar cortex and forebrain [].GlyRs belong to the ligand-gated ion channel family, which also includes the inhibitory gamma-aminobutyric acid type A (GABAA) and excitatory nicotinicacetylcholine (nACh) and serotonin type 3 (5-HT3) receptors [].Affinity-purified GlyR was found to contain two glycosylated membrane proteins of 48kDa and 56kDa, corresponding to alpha and beta subunits,respectively. Four genes encoding alpha subunits have been identified (GLRA1 to 4), together with a single beta polypeptide (GLRB). The heterogeneity ofalpha subunits is further increased by alternative exon splicing, yielding two isoforms of GLRA1 to 3 []. The characteristics of different GlyRsubtypes, therefore, can be largely explained by their GLRA content. GlyRs are generally believed to adopt a pentameric structure in vivo: five subunits assemble to form a ring structure with a central pore. Typically, astoichiometry of 3:2 (alpha:beta) is observed []. GlyR subunits share ahigh overall level of sequence similarity both with themselves and with the subunits of the GABAA and nACh receptors. Four highly conserved segmentshave been proposed to correspond to transmembrane (TM) alpha helices (TM1-4), the second of which is thought to contribute to the pore wall []. A long extracellular N-terminal segment precedes TM1 and a long cytoplasmic loop links TM3 and 4. Short cytoplasmic and extracellular loops join TM1-2 andTM2-3, respectively, and a short C-terminal sequence follows TM4. Studies using radiolabelled strychnine have shown the alpha subunit to beresponsible for ligand binding, the critical residues for this interaction lying within the N-terminal domain. The beta subunit plays a structuralrole, contributing one of its TM domains to the pore wall as well as playing a putative role in postsynaptic clustering of the receptor.In several mammalian species, defects in glycinergic transmission are associated with complex motor disorders. Mutations in the gene encodingGLRA1 give rise to hyperplexia, or startle disease []. This ischaracterised by muscular spasms in response to unexpected light or noise stimuli, similar to the symptoms of sublethal doses of strychnine. Themutations result in amino acid substitutions within the TM1-2 and TM3-4 loops, suggesting that these regions are involved in the transduction ofligand binding into channel activation. In humans, the GLRA2 gene is located on chromosome Xp22.2-22.1 []. In situhybridisation studies have shown GLRA2 to be expressed in the hippocampus,cerebral cortex and thalamus. GLRA2 trancripts predominate in the neonatal and embyonic CNS, and are replaced postnatally by those of GLRA1 and, to alesser extent, GLRA3. Short Name:  Glycine_rcpt_A2

0 Child Features

3 Contains

DB identifier Type Name
IPR006029 Domain Neurotransmitter-gated ion-channel transmembrane domain
IPR006202 Domain Neurotransmitter-gated ion-channel ligand-binding domain
IPR018000 Conserved_site Neurotransmitter-gated ion-channel, conserved site

1 Cross References

Identifier
PR01675

0 Found In

4 GO Annotations

GO Term Gene Name
GO:0016934 IPR008129
GO:0006821 IPR008129
GO:0016021 IPR008129
GO:0045211 IPR008129

4 Ontology Annotations

GO Term Gene Name
GO:0016934 IPR008129
GO:0006821 IPR008129
GO:0016021 IPR008129
GO:0045211 IPR008129

1 Parent Features

DB identifier Type Name
IPR008127 Family Glycine receptor alpha

0 Proteins

13 Publications

First Author Title Year Journal Volume Pages PubMed ID
            1721053
            1846404
            10026168
            18446614
            15383648
            18760291
            15165736
            1323284
            10414351
            11358478
            11396606
            11437237
            9674912